Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3136) 3136
Book Review (1005) 1005
Publication (360) 360
Book / eBook (201) 201
Book Chapter (42) 42
Conference Proceeding (15) 15
Dissertation (6) 6
Newspaper Article (5) 5
Magazine Article (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3012) 3012
index medicus (2915) 2915
female (1526) 1526
papillomaviridae - pathogenicity (999) 999
human papillomavirus (812) 812
animals (801) 801
cancer (756) 756
adult (705) 705
papillomavirus infections (682) 682
virology (680) 680
oncology (624) 624
papillomavirus infections - virology (618) 618
middle aged (606) 606
uterine cervical neoplasms - virology (590) 590
cervical cancer (584) 584
health aspects (583) 583
male (575) 575
viruses (516) 516
infection (485) 485
risk factors (484) 484
research (468) 468
papillomaviridae - genetics (461) 461
microbiology (436) 436
immunology (435) 435
infections (401) 401
infectious diseases (400) 400
human papillomavirus 16 - pathogenicity (382) 382
aged (379) 379
dna (370) 370
proteins (362) 362
analysis (338) 338
research article (338) 338
medicine (331) 331
papillomavirus infections - complications (326) 326
virus diseases (323) 323
hpv (320) 320
prevalence (316) 316
polymerase chain reaction (308) 308
women (297) 297
mice (293) 293
papillomavirus infections - pathology (288) 288
papillomaviruses (286) 286
vaccines (283) 283
papillomavirus infections - epidemiology (278) 278
article (267) 267
genetic aspects (266) 266
adolescent (260) 260
papillomaviridae - isolation & purification (257) 257
uterine cervical neoplasms - pathology (250) 250
cell biology (249) 249
carcinoma, squamous cell - virology (246) 246
gene expression (235) 235
pathology (231) 231
oncogene proteins, viral - genetics (230) 230
epidemiology (229) 229
multidisciplinary sciences (225) 225
medicine, research & experimental (224) 224
expression (220) 220
risk (220) 220
biochemistry & molecular biology (212) 212
dna, viral - genetics (209) 209
cervical-cancer (206) 206
cell line (204) 204
cervical intraepithelial neoplasia - virology (201) 201
deoxyribonucleic acid--dna (201) 201
dna, viral - analysis (201) 201
human papillomavirus 16 - genetics (199) 199
development and progression (195) 195
science (194) 194
vaccination (193) 193
biology (192) 192
young adult (192) 192
squamous-cell carcinoma (190) 190
genotype (188) 188
hiv (187) 187
papillomaviridae - classification (185) 185
diagnosis (183) 183
prevention (183) 183
genomes (175) 175
human-papillomavirus (173) 173
papillomavirus infections - prevention & control (172) 172
studies (170) 170
apoptosis (169) 169
care and treatment (169) 169
review (167) 167
cells (166) 166
carcinoma (161) 161
uterine cervical neoplasms - epidemiology (161) 161
papillomavirus infections - genetics (160) 160
tumors (160) 160
human-papillomavirus type-16 (159) 159
medical research (159) 159
host-pathogen interactions (158) 158
uterine cervical neoplasms - prevention & control (157) 157
papillomavirus infections - diagnosis (156) 156
physiological aspects (155) 155
intraepithelial neoplasia (153) 153
biotechnology & applied microbiology (151) 151
oncogene proteins, viral - metabolism (151) 151
lesions (150) 150
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (152) 152
Collection Dvlpm't (Acquisitions) - Closed Orders (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
UTL at Downsview - May be requested (13) 13
Scarborough Hospital - General (9) 9
UofT at Mississauga - Stacks (9) 9
UofT at Scarborough - Stacks (9) 9
Humber River Regional Hospital - Finch Stacks (6) 6
Dentistry (Harry R Abbott) - Stacks (5) 5
Online Resources - Online (5) 5
Providence Healthcare - Stacks (5) 5
Scarborough Hospital - Birchmount (5) 5
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (4) 4
Lakeridge Health Sciences - Oshawa (4) 4
St. Michael's Hospital - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Credit Valley Hospital - Stacks (3) 3
Dentistry (Harry R Abbott) - Withdrawn (3) 3
Providence Healthcare - Reference (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
UofT at Mississauga - Reference (2) 2
Women's College Hospital - Stacks (2) 2
Baycrest Hospital - Course Reserves (1) 1
Credit Valley Hospital - Reference (1) 1
Dentistry (Harry R Abbott) - May be requested (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - May be requested (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Departmental Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
St Josephs Health Centre - Reference (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Reference (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Scarborough - Sunnybrook Stacks (1) 1
Women's College Hospital - Pharmacy (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3309) 3309
Spanish (22) 22
German (19) 19
French (14) 14
Russian (7) 7
Chinese (6) 6
Japanese (4) 4
Arabic (3) 3
Turkish (2) 2
Czech (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Human papillomavirus and cervical cancer
by Crosbie, Emma J, PhD and Einstein, Mark H, MD and Franceschi, Silvia, MD and Kitchener, Henry C, Prof
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent... 
Internal Medicine | WOMEN | POPULATION | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | VACCINE | HPV INFECTION | FOLLOW-UP | RISK | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
by Paavonen, Jorma, Prof and Jenkins, David, Prof and Bosch, F Xavier, MD and Naud, Paulo, MD and Salmerón, Jorge, DrSC and Wheeler, Cosette M, PhD and Chow, Song-Nan, Prof and Apter, Dan L, MD and Kitchener, Henry C, Prof and Castellsague, Xavier, MD and de Carvalho, Newton S, MD and Skinner, S Rachel, PhD and Harper, Diane M, Prof and Hedrick, James A, MD and Jaisamrarn, Unnop, MD and Limson, Genara AM, MD and Dionne, Marc, MD and Quint, Wim, PhD and Spiessens, Bart, PhD and Peeters, Pascal, MD and Struyf, Frank, MD and Wieting, Susan L, BS and Lehtinen, Matti O, Prof and Dubin, Gary, MD and HPV PATRICIA study grp and HPV PATRICIA study group
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Summary Background The aim of this interim analysis of a large, international phase III study was to assess the efficacy of an AS04 adjuvanted L1... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | PREVENTION | INVASIVE CERVICAL-CANCER | FOLLOW-UP | CLASSIFICATION | MAJOR CAPSID PROTEIN | IDENTIFICATION | HPV | EPITOPES | DNA, Viral - drug effects | Papillomavirus Infections - complications | Human papillomavirus 16 - pathogenicity | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Humans | DNA, Viral - isolation & purification | Human papillomavirus 16 - drug effects | Papillomavirus Vaccines - pharmacology | Cervical Intraepithelial Neoplasia - virology | Cervical Intraepithelial Neoplasia - etiology | Human papillomavirus 18 - drug effects | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Prevention | Research | Demographic aspects | Papillomavirus infections | Papillomaviruses | Analysis | Young women | Clinical trials | Vaccines | Health aspects | Immunization | Young adults | Histology | Infections | Gene expression | Cells | Hepatitis | Human papillomavirus | Womens health | Biopsy | Informed consent | Autoimmune diseases | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials
by Rietbergen, M.M and Brakenhoff, R.H and Bloemena, E and Witte, B.I and Snijders, P.J.F and Heideman, D.A.M and Boon, D and Koljenovic, S and Baatenburg-de Jong, R.J and Leemans, C.R
Annals of Oncology, ISSN 0923-7534, 2013, Volume 24, Issue 11, pp. 2740 - 2745
Background: The presence of human papillomavirus (HPV)-infection in oropharyngeal squamous cell carcinoma (OPSCC) is a major determinant in prognostic risk... 
Oropharyngeal squamous cell carcinoma | P16 | Comorbidity | Survival | Hpv | HEAD | comorbidity | p16 | ONCOLOGY | survival | oropharyngeal squamous cell carcinoma | ALGORITHM | SQUAMOUS-CELL CARCINOMA | VALIDATION | SUBSET | NECK-CANCER | HPV | Oropharyngeal Neoplasms - genetics | Human papillomavirus 16 - pathogenicity | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Survival Rate | Oropharyngeal Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Papillomaviridae - genetics | Papillomaviridae - pathogenicity | Regression Analysis | Human papillomavirus 16 - isolation & purification | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
by Chen, Zigui and Schiffman, Mark and Herrero, Rolando and DeSalle, Rob and Anastos, Kathryn and Segondy, Michel and Sahasrabuddhe, Vikrant V and Gravitt, Patti E and Hsing, Ann W and Burk, Robert D
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 5, pp. e20183 - e20183
Background: Human papillomavirus 16 (HPV16) species group (alpha-9) of the Alphapapillomavirus genus contains HPV16, HPV31, HPV33, HPV35, HPV52, HPV58 and... 
WOMEN | SQUAMOUS INTRAEPITHELIAL LESIONS | HIGH-RISK | PHYLOGENETIC ANALYSIS | MULTIDISCIPLINARY SCIENCES | GENETIC-HETEROGENEITY | INFECTION | TYPE-16 | MULTIPLE SEQUENCE ALIGNMENT | GRADE CERVICAL LESIONS | GENITAL-TRACT | Human papillomavirus 16 - pathogenicity | Human papillomavirus 16 - classification | Humans | Open Reading Frames | Alphapapillomavirus - classification | Phylogeny | Biological Evolution | Genetic Variation | Alphapapillomavirus - pathogenicity | Algorithms | Alphapapillomavirus - genetics | Bayes Theorem | Uterine Cervical Neoplasms - virology | Female | Polymorphism, Single Nucleotide | Genome | Human papillomavirus 16 - genetics | Papillomaviruses | Analysis | Genomics | Genomes | Papillomavirus infections | Epidemiology | Cervical cancer | Pediatrics | Divergence | Taxonomy | Pathogenesis | Viruses | Heterogeneity | Human papillomavirus | Immunology | Phylogenetics | Evolution | Genetics | Deoxyribonucleic acid--DNA | Pathogens | Nucleotide sequence | Therapeutic applications | Nomenclature | Virology | Pathogenicity | Medicine | Studies | Womens health | Sampling methods | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity
by Ahasan, Md Monjurul and Wakae, Kousho and Wang, Zhe and Kitamura, Kouichi and Liu, Guangyan and Koura, Miki and Imayasu, Mieko and Sakamoto, Naoya and Hanaoka, Kousei and Nakamura, Mitsuhiro and Kyo, Satoru and Kondo, Satoru and Fujiwara, Hiroshi and Yoshizaki, Tomokazu and Mori, Seiichiro and Kukimoto, Iwao and Muramatsu, Masamichi
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2015, Volume 457, Issue 3, pp. 295 - 299
Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins are cellular DNA/RNA-editing enzymes that play pivotal roles in the innate... 
APOBEC3 | Pseudovirion | Antiviral activity | HPV16 | INDEPENDENT INHIBITION | DEAMINATION | ENTRY | REVERSE TRANSCRIPTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | TYPE-16 | RESTRICTION | CANCER | BIOPHYSICS | DNA | PROTEINS | BINDING | Oncogene Proteins, Viral - physiology | Genome, Viral | Proteins - physiology | Human papillomavirus 16 - pathogenicity | Human papillomavirus 16 - physiology | Virion - pathogenicity | Cytidine Deaminase - genetics | Humans | Virion - physiology | Virulence | Virion - genetics | Cytidine Deaminase - physiology | Virus Assembly | Host-Pathogen Interactions | Proteins - genetics | Capsid Proteins - physiology | HEK293 Cells | Protein Binding | Female | Human papillomavirus 16 - genetics | Papillomaviruses | Enzymes | RNA | Genomics | Physiological aspects | Papillomavirus infections | Health aspects | Cervical cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
by Hasan, Uzma A and Zannetti, Claudia and Parroche, Peggy and Goutagny, Nadège and Malfroy, Marine and Roblot, Guillaume and Carreira, Christine and Hussain, Ishraq and Müller, Martin and Taylor-Papadimitriou, Joyce and Picard, Didier and Sylla, Bakary S and Trinchieri, Giorgio and Medzhitov, Ruslan and Tommasino, Massimo
Journal of Experimental Medicine, ISSN 0022-1007, 07/2013, Volume 210, Issue 7, pp. 1369 - 1387
Human papillomavirus type 16 (HPV16) and other oncogenic viruses have been reported to deregulate immunity by suppressing the function of the double-stranded... 
PLASMACYTOID DENDRITIC CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | RECOGNITION | MOUSE MODEL | GENE-EXPRESSION | ESTROGEN | TLR9 | IMMUNE FUNCTIONS | CERVICAL-CANCER | SKIN | IMMUNOLOGY | HISTONE DEACETYLASE INHIBITORS | Cervix Uteri - metabolism | Epithelial Cells - metabolism | Humans | Papillomavirus E7 Proteins - immunology | Toll-Like Receptor 9 - genetics | Molecular Sequence Data | Human papillomavirus 16 - immunology | Host-Pathogen Interactions - immunology | Base Sequence | HEK293 Cells | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Repressor Proteins - metabolism | Promoter Regions, Genetic | Human papillomavirus 16 - pathogenicity | Cervix Uteri - virology | Down-Regulation - genetics | Papillomavirus Infections - genetics | Host-Pathogen Interactions - genetics | Epithelial Cells - immunology | Epithelial Cells - virology | Cervix Uteri - immunology | Cell Line, Tumor | HeLa Cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
by Powell, Suzanne E and Hariri, Susan and Steinau, Martin and Bauer, Heidi M and Bennett, Nancy M and Bloch, Karen C and Niccolai, Linda M and Schafer, Sean and Unger, Elizabeth R and Markowitz, Lauri E
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 1, pp. 109 - 113
Highlights ► We describe HPV vaccine status in women with precancerous cervical lesions. ► We examine HPV vaccine impact on HPV 16/18-related precancerous... 
Allergy and Immunology | Vaccine impact | Cervical intraepithelial neoplasia (CIN) | Human papillomavirus (HPV) | Cervical intraepithelial neoplasia (CIN | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | WOMEN | QUADRIVALENT VACCINE | DISPARITIES | EFFICACY | DISEASE | INFECTION | IMMUNOLOGY | Uterine Cervical Diseases - prevention & control | Human papillomavirus 16 - pathogenicity | Papillomavirus Vaccines - therapeutic use | Humans | Papillomaviridae - pathogenicity | Young Adult | Human papillomavirus 18 - pathogenicity | Uterine Cervical Diseases - immunology | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Cervical Intraepithelial Neoplasia - immunology | Virus diseases | Papillomaviruses | Hepatitis | Sexually transmitted diseases | Vaccination | HIV (Viruses) | Public health | Prevalence studies (Epidemiology) | Human papillomavirus | Immunization | Vaccines | Womens health | Cervical cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
by Ault, Kevin A., Dr and Future II Study Grp and Future II Study Group and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9576, pp. 1861 - 1868
Summary Background Cervical cancer and its obligate precursors, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), and adenocarcinona in situ (AIS),... 
Internal Medicine | WOMEN | MEDICINE, GENERAL & INTERNAL | QUADRIVALENT VACCINE | ADOLESCENTS | TYPE-18 | FOLLOW-UP | SUSTAINED EFFICACY | LESIONS | Cervical Intraepithelial Neoplasia - classification | Human papillomavirus 16 - pathogenicity | Double-Blind Method | Follow-Up Studies | Adenocarcinoma - classification | Humans | Human papillomavirus 16 - drug effects | Cervical Intraepithelial Neoplasia - virology | Randomized Controlled Trials as Topic | Adenocarcinoma - prevention & control | Multicenter Studies as Topic | Human papillomavirus 18 - drug effects | Human papillomavirus 18 - pathogenicity | Adolescent | Endpoint Determination | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Papillomavirus Vaccines | Prevention | Complications and side effects | Research | Papillomavirus infections | Cervical cancer | Risk factors | Studies | Medicine | Medical research | Pediatrics | Human papillomavirus | Immunization | Biopsy | Womens health | Clinical trials | Vaccines | Deoxyribonucleic acid--DNA | Adenocarcinoma | Colposcopy | Laboratories | Abnormalities | Vaccination | Viruses | Cervix | Incidence | Randomization | Motivation | Cancer | Index Medicus | Abridged Index Medicus | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Mikrobiologi inom det medicinska området | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis
by Paul M. Weinberger and Ziwei Yu and Bruce G. Haffty and Diane Kowalski and Malini Harigopal and Janet Brandsma and Clarence Sasaki and John Joe and Robert L. Camp and David L. Rimm and Amanda Psyrri
Journal of Clinical Oncology, ISSN 0732-183X, 02/2006, Volume 24, Issue 5, pp. 736 - 747
Purpose We sought to determine the prevalence of biologically relevant human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma (OSCC).... 
HEAD | CYCLE CONTROL | PROTEIN | P16 | ONCOLOGY | ORAL-CANCER | HUMAN FIBROBLASTS | SQUAMOUS-CELL CARCINOMAS | TONSILLAR CARCINOMAS | NECK-CANCER | HPV | Papillomavirus Infections - complications | Human papillomavirus 16 - pathogenicity | Prevalence | Prognosis | Carcinoma, Squamous Cell - epidemiology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Viral Load | Oropharyngeal Neoplasms - classification | Oropharyngeal Neoplasms - epidemiology | Polymerase Chain Reaction | Survival Analysis | Carcinoma, Squamous Cell - classification | Adult | Female | Aged | DNA, Viral | Human papillomavirus 16 - genetics | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Type‐dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18
by Fu Xi, Long and Schiffman, Mark and Ke, Yang and Hughes, James P and Galloway, Denise A and He, Zhonghu and Hulbert, Ayaka and Winer, Rachel L and Koutsky, Laura A and Kiviat, Nancy B
International Journal of Cancer, ISSN 0020-7136, 04/2017, Volume 140, Issue 8, pp. 1747 - 1756
Studies of the clinical relevance of human papillomavirus (HPV) DNA load have focused mainly on HPV16 and HPV18. Data on other oncogenic types are rare. Study... 
viral load | risk association | cervical intraepithelial neoplasia | human papillomavirus | DNA LOAD | CLASSIFICATION | TERM NATURAL-HISTORY | CANCER | LESIONS | CARCINOMA IN-SITU | HPV16 | WOMEN | INTEGRATION | ONCOLOGY | INFECTION | Human papillomavirus 16 - pathogenicity | Early Detection of Cancer | Humans | Papillomavirus Infections - epidemiology | DNA, Viral - isolation & purification | Genotype | Vaginal Smears | Papillomaviridae - genetics | Viral Load | Cervical Intraepithelial Neoplasia - virology | Papillomaviridae - pathogenicity | Human papillomavirus 18 - pathogenicity | Human papillomavirus 31 - genetics | Papillomaviridae - classification | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | DNA, Viral - genetics | Human papillomavirus 31 - pathogenicity | Papillomaviruses | Papillomavirus infections | Cervix dysplasia | Antiretroviral drugs | Human papillomavirus | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights